FDA.reportPublic FDA data

VENROCK

Manufacturer
Guangzhou Oupeng Cosmetics Co., Ltd. | Guangzhou Yishenghe Traditional Chinese Medicine Technology Co., Ltd.
Effective date
2025-06-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:03:29

Label at a glance#

ProductVENROCK
Active ingredientPIROCTONE OLAMINE, SALICYLIC ACID
Label structure11 sections

Indications and uses

Helps prevent and control recurrence of the symptoms of dandruff Helps prevent recurrence of the flaking and itching associated with dandruff

Dosage and administration

Shake well before use Apply to affected areas one to four times daily or as directed by a doctor For best results, use at least twice a week or as directed by a doctor Application: Hold 15-20 cm (4-6 inches) from dry scalp and spray onto affected areas. Use fingertips to massage into scalp for 1-2 minutes until fully absorbed. Do not rinse.

Label contents#

Full prescribing information#

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

  1. Piroctone Olamine 0.5%
  2. Salicylic Acid 1.5%

Purpose(s)

OTC - PURPOSE SECTION

  1. Anti-dandruff (dissolves oil plugs and unclogs pores)
  2. Anti-dandruff (inhibits Malassezia)

Uses

INDICATIONS & USAGE SECTION

  • Helps prevent and control recurrence of the symptoms of dandruff
  • Helps prevent recurrence of the flaking and itching associated with dandruff

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

  • On scalp that is broken or inflamed
  • On children under 12 years of age
  • If you are pregnant

When using this product

OTC - WHEN USING SECTION

  • Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water
  • ​Avoid contact with mucous membranes.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • Condition worsens or does not improve after regular use
  • ​Allergic reaction occurs or irritation persists

PREGNANCY OR BREAST FEEDING SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, get medical help or contact a Poison Control Center right away

Directions

DOSAGE & ADMINISTRATION SECTION

  • Shake well before use
  • Apply to affected areas one to four times daily or as directed by a doctor
  • For best results, use at least twice a week or as directed by a doctor
  • Application: Hold 15-20 cm (4-6 inches) from dry scalp and spray onto affected areas. Use fingertips to massage into scalp for 1-2 minutes until fully absorbed. Do not rinse.

Other information

OTHER SAFETY INFORMATION

Store in a cool, dry place away from direct sunlight

Inactive ingredients

INACTIVE INGREDIENT SECTION

AQUA, ALCOHOL, PROPYLENE GLYCOL, SALICYLIC ACID, PEG-40 HYDROGENATED CASTOR OIL, GLYCERETH-25 PCA ISOSTEARATE, CINNAMOMUM CAMPHORA (CAMPHOR) LEAF OIL, PHENOXYETHANOL, MENTHOL, COCAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE, PIROCTONE OLAMINE, BENZOIC ACID, BUTYLENE GLYCOL, SWERTIA CHIRATA EXTRACT, GENTIANA MACROPHYLLA ROOT EXTRACT, GENTIANA SCABRA EXTRACT

Questions or comments?

OTC - QUESTIONS SECTION

934-935-7135 / Yiqinzhi726@gmail.com

Box Front Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

VENROCK

ANTI-DANDRUFF SPRAY


2X SCIENCE-BASED SOLUTION
DERMATOLOGICALLY TESTED


- 0.5% Piroctone Olamine
- 1.5% Salicylic Acid


SPRAY


√ pH 6 optimized for scalp microbiome
√ 16% faster dandruff clearance vs monotherapy


NET: 100 ml / 3.38 fl.oz

VENROCK ANTI-DANDRUFF SPRAYVENROCK ANTI-DANDRUFF SPRAY

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2717186piroctone olamine 0.5 % / salicylic acid 1.5 % Topical SprayPSN1
2717186piroctone olamine 5 MG/ML / salicylic acid 15 MG/ML Topical SpraySCD1
2717186piroctone olamine 0.5 % / salicylic acid 1.5 % Topical SpraySY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
85772-0002-1VENROCK1 g in 1 BOXSPRAY11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85772-000285772-0002-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Name, UNII, Kind table
NameUNIIKind
PIROCTONE OLAMINEA4V5C6R9FBACTIB
PHENOXYETHANOLHIE492ZZ3TIACT
POLYOXYL 40 HYDROGENATED CASTOR OIL7YC686GQ8FIACT
ALCOHOL3K9958V90MIACT
SALICYLIC ACIDO414PZ4LPZACTIB
BUTYLENE GLYCOL3XUS85K0RAIACT
SWERTIA CHIRAYITA LEAFU0787KJ43QIACT
GENTIANA MACROPHYLLA ROOT6559FC0U1BIACT
AQUA059QF0KO0RIACT
GLYCERETH-25 PCA ISOSTEARATETV85Z17HAZIACT
MENTHOLL7T10EIP3AIACT
BENZOIC ACID8SKN0B0MIMIACT
GENTIANA SCABRA ROOTGXZ33VNT92IACT
PROPYLENE GLYCOL6DC9Q167V3IACT
COCAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATEH2KVQ74JM4IACT
CINNAMOMUM CAMPHORA (CAMPHOR) LEAF OIL51D0RGY52VIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VENROCKPIROCTONE OLAMINE AND SALICYLIC ACIDGuangzhou Oupeng Cosmetics Co., Ltd.372feca7-f6f1-cd38-e063-6294a90a3bfe2025-06-12WarningsExact identifier
ndc (package): 85772-0002-1
ndc (product): 85772-0002
ndc11 (package): 85772000201
spl id: 372feca7-f6f2-cd38-e063-6294a90a3bfe
spl set id: 372feca7-f6f1-cd38-e063-6294a90a3bfe

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.